This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.
At a glance
Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.
An open check means the public sources were not specific enough—not that the service failed the check.
Resumen en español
FuturHealth para usuarios hispanohablantes
Esta sección ofrece una orientación breve en español sobre el perfil estadounidense. La investigación completa de precios, acceso, farmacia y seguimiento permanece arriba mientras ampliamos la revisión editorial en español.
No encontramos una fuente primaria suficientemente específica para afirmar que una cita clínica esté disponible en español. Confirma el idioma y cualquier servicio de interpretación antes de pagar.
- si la cita concreta será en español;
- el coste mensual ordinario y qué incluye;
- la licencia estatal del profesional;
- el medicamento, la farmacia y el coste por separado.
Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.
Comparar proveedores para hispanohablantes en EE. UU. →How the program is structured
A subscription combining clinician-guided medication access, a digital platform, nutrition planning, and Apple Fitness+. Public pages name both injections and pills but do not disclose a stable ordinary recurring total or named pharmacy before intake.
GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.
Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.
Service configuration
These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.
- Provider type
- Telehealth program
- Medicine context
- Semaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes)
- Formats reviewed
- Injection · Oral medicine
- Funding routes
- Private pay
- Service features
- Coaching · Clinician support · Switching pathway · Home delivery
- Access check
- Confirm current state access
- Evidence status
- Primary sources reviewed
- Research depth
- 2 cited sources · 3 medicine rows · 5 open checks
Recurring cost breakdown
- Subscription includes the digital program, clinical guidance, and personalized nutrition plan.
- Medication access is advertised as included in some program wording, but the exact product price, term, and renewal total are not public beside the main offer.
- Insurance is not required; HSA/FSA eligibility is advertised.
- Meal delivery and other add-ons should be treated as separate unless checkout explicitly includes them.
- Medicine + dose
- Membership or consultation
- Delivery + supplies
- Labs + follow-up
- Renewal after offers
Medication and formulation matrix
| Medication | Form | Regulatory / program path | Published price view |
|---|---|---|---|
| Ozempic / Mounjaro | Weekly injection | FDA-approved for type 2 diabetes | Not public on reviewed landing page |
| Zepbound and other GLP-1/GIP options | Injection | Brand/other route must be confirmed | Not public on reviewed landing page |
| Pill options | Oral | Exact drug and approval status must be disclosed | Not public on reviewed landing page |
Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.
State-by-state availability
- US-based licensed clinicians and pharmacies are advertised.
- A complete state-by-product table was not located on the reviewed public page.
Clinician access and follow-up cadence
- Consistent support from medical professionals is advertised.
- No fixed appointment schedule or guaranteed response time is published on the main page.
Pharmacy and fulfillment
- FuturHealth says it works with licensed US-based pharmacies and FDA-approved manufacturers.
- The specific dispensing pharmacy and shipment interval are not named before intake.
Insurance and prior authorization
- No insurance is required for the marketed program.
- A formal prior-authorization workflow was not confirmed on the reviewed page.
Cancellation, refund, and commitment
- The footer links a dedicated billing and refunds policy.
- The full cancellation cutoff, processed-order rule, and refund eligibility must be checked against the offer accepted at checkout.
Labs, monitoring, and dose management
- A standard included lab panel and repeat schedule were not publicly confirmed.
- Ask what safety monitoring applies to the exact drug.
Maintenance and switching
- The main page does not publish an established-dose transfer protocol.
- Confirm prescription history, current dose, last fill, and expected delivery before moving care.
Program snapshot
Program plus treatment
Profiled support: Ongoing clinician access, Coaching or behavior support.
Cash pay
Confirm whether any presented brand path uses insurance or direct pay.
Verify before purchase
Ask for the pharmacy and whether fulfillment differs across products.
What the advertised program may include
- Online clinical process
- Medication access when prescribed
- Nutrition planning
- Digital support tools
Useful comparison signals
Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.
- Starting care and comparing first-provider requirements
- Switching providers or continuing an established treatment
- Ongoing clinician access
- Coaching or behavior support
Open evidence gaps
These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.
- Ordinary recurring total
- Named pharmacy
- State-by-product table
- Medication-specific terms
- Lab and follow-up cadence
Questions to ask before paying
- What is the ordinary recurring total after any introductory period?
- Does that total include clinician care, medication, supplies, labs, and shipping?
- Which clinician group and dispensing pharmacy will be responsible for my care?
- What happens to billing if I am not prescribed the advertised treatment?
- What records and timing do you require if I am switching from another provider?
Source ledger
Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.
Program components, medication categories, clinician and pharmacy claims
Contract and subscription framework